Publication
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Journal Paper/Review - Apr 13, 2018
Wicki Andreas, Tzankov Alexandar, Hess Viviane, Childs Alexa, Hierro Cinta, Rodón Jordi, Hess Dagmar, Jörger Markus, von Moos Roger, Sessa Cristiana, Ritschard Reto, Prêtre Vincent, Herrmann Richard, Brown Nicholas, Xyrafas Alexandros, Bize Vincent, Hawle Hanne, Berardi Simona, Cmiljanović Nataša, Cmiljanović Vladimir, Stumm Michael, Dimitrijević Saša, Kristeleit Rebecca
Wicki, Andreas
4
0
Brown, Nicholas
1
0
Xyrafas, Alexandros
6
0
Bize, Vincent
2
0
Hawle, Hanne
13
0
Berardi, Simona
3
0
Cmiljanović, Nataša
1
0
Cmiljanović, Vladimir
1
0
Stumm, Michael
1
0
Dimitrijević, Saša
1
0
Herrmann, Richard
11
0
Prêtre, Vincent
1
0
Ritschard, Reto
1
0
Tzankov, Alexandar
7
0
Hess, Viviane
6
0
Childs, Alexa
1
0
Hierro, Cinta
1
0
Rodón, Jordi
4
0
Hess, Dagmar
Medizinische Onkologie und Hämatologie · Dept. I
26
17
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
175
42